A lot of the discussion around GLP-1 medicines in recent years has highlighted the risks linked with rapid weight loss.

Combining the popular weight-loss medication tirzepatide with another hormone mimic may boost the drug’s effectiveness, ...

The most common side effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation. The drugs have also been ...

People who switched from an injectable GLP-1 weight loss medication to the Wegovy pill continued to lose weight over the next ...

It leads to nearly triple the weight loss of the others in the same time period.

A recent Phase III clinical trial, TRIUMPH-2, evaluated the efficacy and safety of retatrutide, a triple receptor agonist and ...

As people flock to GLP-1 drugs, what do consumers need to know about the side effects, risks, benefits, and bonuses?

An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s, researchers report. The weekly injected ...

Share on Pinterest Research shows that microdosing GLP-1 medications may still lead to weight loss. Tatsiana Volkava · Moment/Getty Recent research suggests that people may still lose weight while ...

Once-weekly retatrutide induced weight loss of up to 18.8% at 80 weeks for adults with type 2 diabetes plus overweight or obesity, according to findings from the phase 3 TRIUMPH-2 trial. As Healio ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular in recent years. For people who haven't had success with diet and exercise alone, these medications can help support ...

New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of ...